Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RUNDC3A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MSH5-SAPCD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | B3GAT1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | P2RY2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RNF168 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C12orf73 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNRF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SPIN4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | WBP2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |